Get the Stockscreener App
4.25
3.41%
-0.15
Pre-market:
4.25
Capsovision Inc stock is traded at $4.25, with a volume of 13,586.
It is down -3.41% in the last 24 hours and up +0.00% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.
See More
Previous Close:
$4.40
Open:
$4.25
24h Volume:
13,586
Relative Volume:
1.60
Market Cap:
$195.90M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.71%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.25
$4.30
1-Week Range:
$4.15
$4.8816
52-Week Range:
$4.15
$4.8816
Capsovision Inc Stock (CV) Company Profile
Compare CV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
4.25 | 203.91M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Capsovision Inc Stock (CV) Latest News
CapsoVision Completes $27.5 Million Nasdaq IPO - Global Legal Chronicle
CapsoVision enters development agreement with Canon and announces partial IPO overallotment exercise - Investing.com South Africa
CapsoVision Raises $600,000 Through IPO Overallotment - TipRanks
CapsoVision prices $27.5M IPO - MSN
Why Did CapsoVision Plunge 10.45% After IPO Pricing? - AInvest
CapsoVision's IPO: A Pill to Swallow in the GI Diagnostics Market? - AInvest
CapsoVision Soars 40.31% on IPO Debut - AInvest
CapsoVision Closes $27.5 Million IPO; Shares Rebound - MarketScreener
CapsoVision, Inc. Successfully Closes Initial Public Offering Raising $27.5 Million - Nasdaq
CapsoVision Announces Closing of Initial Public Offering - GlobeNewswire
CapsoVision Stocks: Bursting Bubbles or Rising Stars? - StocksToTrade
CapsoVision’s Wild Ride: Why This Med-Tech Newcomer Is Turning Heads on Nasdaq - RagingBull
CapsoVision’s Rollercoaster: Risk or Reward? - timothysykes.com
CapsoVision, Inc.(NasdaqCM: CV) added to NASDAQ Composite Index - MarketScreener
CapsoVision begins trading on Nasdaq at $5 per share, declines since - Investing.com India
CV IPO NewsMedical device maker CapsoVision prices IPO at $5, the low end of the range - renaissancecapital.com
CapsoVision Prices 5.5M Share IPO at $5/sh - Investing.com Australia
CapsoVision Prices 5.5M Share IPO at $5/sh By Investing.com - Investing.com Canada
Capsovision Announces Pricing Of Initial Public Offering - TradingView
Med-tech IPOs gain steam going into Q3 - BioWorld MedTech
CapsoVision Aims to Swallow GI Imaging Market – $28M Nasdaq Debut Eyes AI-Powered Diagnostic Future - Minichart
CapsoVision, Inc. (CV) Announces July 2nd IPO - Defense World
CapsoVision IPO: Key Details and Insights into the Company’s Market Debut - AInvest
Caris settles IPO at $21, trading starts at $28 - BioWorld MedTech
CapsoVision Proposes IPO Terms For GI Tract Imaging Capsule Technology (Pending:CV) - Seeking Alpha
Three med-tech IPOs on the horizon - BioWorld MedTech
Capsule endoscopy developer CapsoVision files $30M IPO - Fierce Biotech
CapsoVision Inc’s IPO: A Groundbreaking Play in Medical Imaging? - AInvest
CapsoVision's CapsoCam Plus® Capsule Endoscopy System Earns FDA Clearance to Continue Remote Ingestion, Further Expanding Access and Comfort for Patients - The Malaysian Reserve
CapsoVision's CapsoCam Plus® Capsule Endoscopy System Receives FDA Clearance for Pediatric Use, Offering a Comfortable, Child-Friendly Solution for Young Patients - PR Newswire
Global Smart Pills Technologies Industry is poised for a substantial surge, targeting US$ 6176 Milli - PharmiWeb.com
Capsule Endoscopes Market Size (2022-2030)Advin Healthcare, CapsoVision Inc, Fujifilm Holding Corporation, Koninklijke Philips NV, Medtronic Plc and Olympus Corporation - Yahoo Finance
CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19 - PR Newswire
Ingestible Sensors Market Is Likely to Experience a Tremendous - openPR.com
CapsoVision Announces U.S. Distribution Partnership With PENTAX Medical - GlobeNewswire
UPDATE -- CapsoVision, Inc. Announces CE Mark for the Use - GlobeNewswire
CapsoVision Enhances CapsoCam Plus Capsule Endoscopy System With CapsoCloud - Medical Design & Outsourcing
CapsoVision, Inc. Announces FDA 510(k) Clearance For CapsoCam Plus - Med Device Online
Capsovision Inc Stock (CV) Financials Data
There is no financial data for Capsovision Inc (CV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):